Directionally Sensitive Fractal Radiomics Compatible With Irregularly Shaped Magnetic Resonance Tumor Regions of Interest: Association With Osteosarcoma ChemoresistanceJOURNAL OF MAGNETIC RESONANCE IMAGINGIF3.52022-05-134PRE
Relative apparent diffusion coefficient (rADC) in breast lesions of uncertain malignant potential (B3 lesions) and pathologically proven breast carcinoma (B5 lesions) following breast biopsyEUROPEAN JOURNAL OF RADIOLOGYIF3.32020-03-015PRE
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinomaCELLULAR ONCOLOGYIF4.82018-05-2226PREAI
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinomaCELLULAR ONCOLOGYIF4.82016-11-0742OAAI
Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinomaTRANSLATIONAL RESEARCHIF5.92014-11-0150PREAI
Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: Ductal carcinoma in situ vs. invasive ductal carcinomaEUROPEAN JOURNAL OF RADIOLOGYIF3.32014-08-0113PREAI
CHANGES IN THE COAGULATION FUNCTIONS IN THE TRANSPLANTATION OF THE LIVER - SINGLE CENTER EXPERIENCETHROMBOSIS RESEARCHIF3.42014-05-010PREAI
The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulationEXPERIMENTAL CELL RESEARCHIF3.52013-04-0133PREAI
Characterization of Newly Established P-glycoprotein Over-expressing Multi-drug Resistant Human Cancer Cell LinesEUROPEAN JOURNAL OF CANCERIF7.12012-07-010OAAI
NK-lysin Derived Peptide (NK-2) Sensitizes Resistant Cancer Cells to Classic Chemotherapeutics by Selective Killing of P-glycoprotein Over-expressing CellsEUROPEAN JOURNAL OF CANCERIF7.12012-07-010PREAI